Product Information
LORAZEPAM 0.5 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.0329 per EA under NDC 13107008301. Its NADAC has been published 255 times since Aug 11, 2021.
Strength
.5 mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107008301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA203572On Market Since
2/1/2021
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 0.5 MG TABLET has been published 255 times since Aug 11, 2021, and over the history we have for it it has declined 25.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0329 per EA |
|---|---|
| All-time high | $0.0464 (Mar 13, 2024) |
| All-time low | $0.0315 (Nov 20, 2024) |
| 52-week high | $0.0439 |
| 52-week low | $0.0329 |
| Median price | $0.0402 |
| Average price | $0.0399 |
| Largest weekly change | +28.1% (Aug 21, 2024) |
| Weeks tracked | 255 |
| Tracking since | Aug 11, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LORAZEPAM 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 0.5 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.0329 per EA (NDC 13107008301), effective Jun 24, 2026.
How has the price of LORAZEPAM 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 0.5 MG TABLET has declined 25.9%. It has been tracked across 255 weekly CMS publications since Aug 11, 2021.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 0.5 MG TABLET?
Since Aug 11, 2021, the NADAC for LORAZEPAM 0.5 MG TABLET has ranged from a low of $0.0315 (Nov 20, 2024) to a high of $0.0464 (Mar 13, 2024), with a median of $0.0402 per EA.
Are there cheaper alternatives to LORAZEPAM 0.5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as LORAZEPAM 0.5 MG TABLET, but none are currently priced below it.
Who manufactures LORAZEPAM 0.5 MG TABLET?
LORAZEPAM 0.5 MG TABLET (NDC 13107008301) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification